# Oxaliplatin

NDC: 31722-358
Generic name: Oxaliplatin
Labeler / Manufacturer: Camber Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION, CONCENTRATE
Routes: INTRAVENOUS
Marketing started: 20250127

FDA application: ANDA217925

## Active ingredients

- OXALIPLATIN: 100 mg/20mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"31722-358"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=31722-358
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b0799e39-7b1e-430a-b159-062b39521001